Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Minervax ApS
Under deal amendment, Innovent gets Asia rights to Cyramza, Retevmo and pirtobrutinib.
Private Company Watch: Neuron23, Neurogene and Locanabio each raised $100m or more, highlighting increased investor interest in novel approaches to neurological diseases. Also, CRO dMed raised $100m and MinervaX brought in $57m for its vaccine to protect newborns.